The Safety and Efficacy of the Regimen of Thiotepa + Fludarabine +Granulocyte Colony-Stimulating Factor+ Cytarabine + Busulfan in Single Unrelated Umbilical Cord Blood Transplantation

NCT07441967 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Hematologic Malignancies

Interventions

DRUG: Thiotepa
DRUG: Fludarabine
DRUG: G-CSF
DRUG: cytarabine
DRUG: busulfan

Sponsor

Institute of Hematology & Blood Diseases Hospital, China